An ‘in­no­cent by­stander’ in the boom­ing biotech in­vestor world is writ­ing a blank check for $100M. Who’s go­ing to cash it?

Sri­ni Akkara­ju’s LinkedIn pro­file de­scribes his work as a “biotech in­vestor (aka in­no­cent by­stander)” with tongue-in-cheek mod­esty. But he’s been deeply steeped in the ways …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER